Stuart J. Brink

2.5k total citations
56 papers, 1.6k citations indexed

About

Stuart J. Brink is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Stuart J. Brink has authored 56 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Endocrinology, Diabetes and Metabolism, 27 papers in Genetics and 15 papers in Surgery. Recurrent topics in Stuart J. Brink's work include Diabetes Management and Research (28 papers), Diabetes and associated disorders (25 papers) and Pancreatic function and diabetes (13 papers). Stuart J. Brink is often cited by papers focused on Diabetes Management and Research (28 papers), Diabetes and associated disorders (25 papers) and Pancreatic function and diabetes (13 papers). Stuart J. Brink collaborates with scholars based in United States, Australia and Sweden. Stuart J. Brink's co-authors include Hildreth Y. Grossman, Stuart T. Hauser, Chester A. Alper, Zuheir L. Awdeh, Edmond J. Yunis, Deborah Marcus-Bagley, Margot S. Kruskall, George S. Eisenbarth, J. Stuart Soeldner and Donald E. Craven and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Investigation.

In The Last Decade

Stuart J. Brink

54 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stuart J. Brink United States 20 847 628 477 315 253 56 1.6k
Henry G. Herrod United States 26 275 0.3× 259 0.4× 228 0.5× 374 1.2× 647 2.6× 91 2.0k
Lesley G. King United States 30 128 0.2× 326 0.5× 463 1.0× 267 0.8× 58 0.2× 80 2.2k
Fay J. Hosking United Kingdom 21 253 0.3× 320 0.5× 126 0.3× 416 1.3× 108 0.4× 28 1.9k
Clifford W. Bogue United States 23 115 0.1× 218 0.3× 411 0.9× 106 0.3× 146 0.6× 44 1.4k
Stephen L. Corson United States 32 108 0.1× 259 0.4× 471 1.0× 445 1.4× 241 1.0× 159 3.3k
J.G. Westergaard Denmark 30 391 0.5× 234 0.4× 731 1.5× 267 0.8× 238 0.9× 85 3.4k
Courtney McCracken United States 19 153 0.2× 119 0.2× 173 0.4× 416 1.3× 49 0.2× 66 1.3k
Esther J. Israel United States 18 49 0.1× 362 0.6× 326 0.7× 332 1.1× 353 1.4× 49 1.7k
J. Lansac France 32 114 0.1× 529 0.8× 603 1.3× 253 0.8× 96 0.4× 166 3.7k
Mikael Andersson Denmark 22 44 0.1× 878 1.4× 476 1.0× 900 2.9× 175 0.7× 66 1.8k

Countries citing papers authored by Stuart J. Brink

Since Specialization
Citations

This map shows the geographic impact of Stuart J. Brink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart J. Brink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart J. Brink more than expected).

Fields of papers citing papers by Stuart J. Brink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart J. Brink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart J. Brink. The network helps show where Stuart J. Brink may publish in the future.

Co-authorship network of co-authors of Stuart J. Brink

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart J. Brink. A scholar is included among the top collaborators of Stuart J. Brink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart J. Brink. Stuart J. Brink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Virmani, Anju, Stuart J. Brink, Angela Middlehurst, et al.. (2022). ISPAD Clinical Practice Consensus Guidelines 2022: Management of the child, adolescent, and young adult with diabetes in limited resource settings. Pediatric Diabetes. 23(8). 1529–1551. 16 indexed citations
2.
Brink, Stuart J.. (2022). Insulin Past, Present, and Future: 100 Years from Leonard Thompson. Diabetology. 3(1). 117–158. 5 indexed citations
3.
Priyambada, Leena, Joseph I. Wolfsdorf, Stuart J. Brink, et al.. (2020). ISPAD Clinical Practice Consensus Guideline: Diabetic ketoacidosis in the time of COVID ‐19 and resource‐limited settings‐role of subcutaneous insulin. Pediatric Diabetes. 21(8). 1394–1402. 19 indexed citations
4.
Mitchell, Marvin L., Ho-Wen Hsu, Stuart J. Brink, et al.. (2016). Unresolved Issues in the Wake of Newborn Screening for Congenital Hypothyroidism. The Journal of Pediatrics. 173. 228–231.e1. 9 indexed citations
5.
Brink, Stuart J., Dipesalema Joel, Lori M. Laffel, et al.. (2014). Sick day management in children and adolescents with diabetes. Pediatric Diabetes. 15(S20). 193–202. 17 indexed citations
6.
Zacharin, Margaret, Jean‐Pierre Chanoine, Fernando Cassorla, et al.. (2013). Promoting Excellence in the Care of Pediatric Endocrine Diseases in the Developing World. PEDIATRICS. 131(2). e573–e578. 15 indexed citations
7.
Brink, Stuart J., et al.. (2009). Management of children and adolescents with diabetes requiring surgery. Pediatric Diabetes. 10. 169–174. 8 indexed citations
8.
Brink, Stuart J., et al.. (2007). Management of children with diabetes requiring surgery. Pediatric Diabetes. 8(4). 242–247. 5 indexed citations
9.
Brink, Stuart J., Michael E. Miller, & Kathleen Moltz. (2002). Education and Multidisciplinary Team Care Concepts for Pediatric and Adolescent Diabetes Mellitus. Journal of Pediatric Endocrinology and Metabolism. 15(8). 1113–30. 54 indexed citations
10.
Brink, Stuart J.. (2001). Complications of pediatric and adolescent type 1 diabetes mellitus. Current Diabetes Reports. 1(1). 47–55. 31 indexed citations
11.
Alper, Chester A., Deborah Marcus-Bagley, Z Awdeh, et al.. (2000). Prospective analysis suggests susceptibility genes for deficiencies of IgA and several other immunoglobulins on the [HLA‐B8, SC01, DR3] conserved extended haplotype. Tissue Antigens. 56(3). 207–216. 35 indexed citations
12.
Brink, Stuart J.. (1998). HMOs were the right Rx. Americans got lower medical costs--but also more worries.. PubMed. 124(9). 47–50. 3 indexed citations
13.
Brink, Stuart J.. (1997). How to Apply the Experience from the Diabetes Control and Complications Trial to Children and Adolescents?. Annals of Medicine. 29(5). 425–438. 30 indexed citations
14.
Simon, Susan, L Truedsson, Deborah Marcus-Bagley, et al.. (1997). Relationship Between Protein Complotypes and DNA Variant Haplotypes: Complotype-RFLP Constellations (CRC). Human Immunology. 57(1). 27–36. 14 indexed citations
15.
Garcı́a-Merino, Antonio, Chester A. Alper, Koichiro Usuku, et al.. (1996). Tumor Necrosis Pactor (TNF) microsatellite haplotypes in relation to extended haplotypes, susceptibility to diseases associated with the major histocompatibility complex and TNF secretion. Human Immunology. 50(1). 11–21. 66 indexed citations
16.
Simon, Susan, Z Awdeh, R. Duncan Campbell, et al.. (1991). A restriction fragment of the C2 gene is a unique marker for C2 deficiency and the uncommon C2 allele C2*B (a marker for type 1 diabetes).. Journal of Clinical Investigation. 88(6). 2142–2145. 8 indexed citations
17.
18.
Alper, Chester A., Margot S. Kruskall, Deborah Marcus-Bagley, et al.. (1989). Genetic Prediction of Nonresponse to Hepatitis B Vaccine. New England Journal of Medicine. 321(11). 708–712. 330 indexed citations
19.
Brink, Stuart J., et al.. (1986). Prognostic factors in multiple myeloma.. PubMed. 69(1). 35–8. 2 indexed citations
20.
Ganda, Om P., S. Srikanta, Stuart J. Brink, et al.. (1984). Differential Sensitivity to β-Cell Secretagogues in “Early,” Type I Diabetes Mellitus. Diabetes. 33(6). 516–521. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henry G. Herrod Breakdown of academic impact, for papers by Lesley G. King Breakdown of academic impact, for papers by Fay J. Hosking Breakdown of academic impact, for papers by Clifford W. Bogue Breakdown of academic impact, for papers by Stephen L. Corson Breakdown of academic impact, for papers by J.G. Westergaard Breakdown of academic impact, for papers by Courtney McCracken Breakdown of academic impact, for papers by Esther J. Israel Breakdown of academic impact, for papers by J. Lansac Breakdown of academic impact, for papers by Mikael Andersson
Rankless by CCL
2026